CancerX Member Organizations
Our members drive the success of CancerX, collaborating to set priorities and practices that will help us harness the full power of innovation.
Impact Supporter
Member Organizations
Our members drive the success of CancerX, collaborating to set priorities and practices that will help us achieve our mission.
Members also include the National Cancer Institute
Steering Committee
CancerX’s steering committee provides an additional layer of governance within CancerX’s public-private partnership model.
Shirin Ahmed, Head of Medical Innovation, Strategy & Operations
AstraZeneca
Rasu Shrestha, Chief Innovation & Commercialization Officer, Atrium Health
Ben Moscovitch, Healthcare and Life Science Public Policy Lead, Americas, Amazon Web Services (AWS)
Sally Werner, Chief Executive Officer, Cancer Support Community
Mary Tolikas, Senior Vice President and Chief Innovation Officer, Dana-Farber Cancer Institute
Omid Toloui, Vice President, Innovation, Elevance Health
Ryan Smith, Chief Executive Officer, Graphite Health
Ashita S. Batavia, MD MS
Head of Hematology & Oncology Data Sciences, Research & Development, J&J Innovative Medicine
Andrea Downing, Chief Executive Officer, Light Collective
Cait Brumme, Chief Executive Officer, MassChallenge
Matt Bettonville, Investor, Yosemite
